Neurosurgery

Latest Issue of OR Manager
March 2025
Home Surgery/Specialties > Neurosurgery

Laser-based imaging system, AI algorithm accurately identify brain tumors

Editor's Note Researchers at NYU Langone Health combined advanced optical imaging with an artificial intelligence (AI) algorithm to produce accurate, real-time intraoperative diagnosis of brain tumors in this study. Compared with the accuracy of pathologists’ interpretation of conventional histologic images, the results for both methods were comparable. The AI-based diagnosis…

Read More

By: Judy Mathias
January 7, 2020
Share

FDA: Class I recall of LivaNova VNS Therapy SenTiva Generator

Editor's Note The Food & Drug Administration (FDA) on January 2 identified the recall by LivaNova of its VNS Therapy SenTiva Generator System as Class I, the most serious. The recall was initiated because of an unintended reset error that causes the system to stop delivering vagus nerve stimulation therapy…

Read More

By: Judy Mathias
January 7, 2020
Share

AI algorithms predict mortality after traumatic brain injury

Editor's Note Two artificial intelligence-based algorithms predicted the probability of a patient dying in the ICU within 30 days of traumatic brain injury with accuracies up to 81% and 84%, in this study from Finland. The first algorithm is based on objective monitor data, and the second one includes data…

Read More

By: Judy Mathias
December 3, 2019
Share

FDA: Class I recall of Zimmer Biomet’s ROSA Brain 3.0 Robotic Surgery System

Editor's Note The Food & Drug Administration on November 7 identified the recall by Zimmer Biomet of its ROSA Brain 3.0 Robotic Surgery System as Class I, the most serious. The recall was initiated because of a software issue that incorrectly positions the robotic arm. The company has received five…

Read More

By: Judy Mathias
November 14, 2019
Share

Sponsored Message

FDA: Class I recall of Integra LifeSciences CSF drainage, ICP monitoring systems

Editor's Note The Food & Drug Administration on May 24 identified the recall by Integra LifeSciences of its LimiTorr Volume Limiting Cerebrospinal Fluid (CSF) Drainage System and the MoniTorr Intracranial Pressure (ICP) External CSF Drainage and Monitoring System as Class I, the most serious. The recall was initiated because of…

Read More

By: Judy Mathias
May 28, 2019
Share

FDA grants Stryker premarket approval for intracranial aneurysm stent

Editor's Note Stryker announced on May 20 that the Food & Drug Administration (FDA) granted premarket approval for its Neuroform Atlas stent system for intracranial aneurysms, the May 20 MassDevice reports.   The self-expanding nitinol stent can now be used with neurovascular embolization coils to treat patients with saccular wide-necked…

Read More

By: Judy Mathias
May 23, 2019
Share

Sponsored Message

FDA: Class I recall of Neuro Omega System

Editor's Note The Food and Drug Administration (FDA) on May 6 identified the recall my Alpha Omega Engineering of its Neuro Omega System, including the Drive Headstage unit, as Class I, the most serious. The recall was initiated because a design flaw in the device may connect two separate electrode…

Read More

By: Judy Mathias
May 8, 2019
Share

FDA issues Safety Communication for Stryker Wingspan Stent System

Editor's Note The Food and Drug Administration (FDA) on April 25 issued a Safety Communication on use of the Stryker Wingspan Stent System outside of approved indications. The Wingspan Stent System is used to open narrowed arteries in the brains of patients with intracranial stenosis who are experiencing repeated strokes.…

Read More

By: Judy Mathias
April 29, 2019
Share

FDA: Class I recall of Medtronic’s Synergy, Stealth Station S7 Cranial Software

Editor's Note The Food & Drug Administration (FDA) on January 8 identified the recall of Medtronic’s Synergy Cranial Software and Stealth Station S7 Cranial Software as Class I, the most serious. The Software is used with the Stealth Station Surgical Navigation System to provide detailed 3D images of a patient’s…

Read More

By: Judy Mathias
January 10, 2019
Share

FDA: Class I recall of Synaptive Medical’s BrightMatter Guide with SurfaceTrace Registration

Editor's Note The Food and Drug Administration (FDA) on November 30 identified the recall by Synaptive Medical of its BrightMatter Guide with SurfaceTrace Registration, which is used to perform neurosurgical procedures, as Class I, the most serious. The recall was initiated because of a software defect that could potentially result…

Read More

By: Judy Mathias
December 4, 2018
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat